glp 1 and atrial fibrillation For patients with obesity fibrillation, GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/arrhythmias/120327 Cardiovascular Protective Properties of GLP-1

Ipamorelin does not have a comparable body of cardiac research literature

First characterized by Sikiric et al

Due to their preclinical testing and lack of comparison with other dual receptor agonists such as tirzepatide, further studies are needed to determine whether the effects of these unimolecular compounds are superior to those of clinically tested drugs

The lightweight, non-greasy design adheres comfortably to the skin, making them suitable for use at home, work, travel, or during daily activities

found that exendin-4 increased the membrane protein level of the AMPA receptor GluR1 subunit and postsynaptic density protein-95, which were the critical mechanisms of long-term potentiation (LTP) as well as the formation of learning and memory (178)